Hyperkalemia After Hospitalization For Heart Failure With Reduced Ejection Fraction: Findings From The Astronaut Trial

Muthiah Vaduganathan,Manan Pareek,Kamya Sankar,Baljash Cheema,Haris Subacius,Gregg C. Fonarow, Scott Solomon,Eldrin Lewis,Aldo Maggioni, Michael Boehm,Faiez Zannad,Javed Butler,Mihai Gheorghiade

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览19

暂无评分

摘要

Hyperkalemia (hyperK+) may limit the optimal use of RAAS inhibitors and represents an emerging target for therapy. We report rates, temporal patterns, and key predictors of hyperK+ after hospitalization for HFrEF. The ASTRONAUT trial randomized 1,639 HFrEF patients with EF≤ 40% and elevated NP

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要